The side hustle is at an all-time high with the internet connecting the entrepreneur-minded with technology that can develop ...

Shares of Steelcase Inc. fell after hours on Wednesday, after the office-furniture maker’s second-quarter outlook disappointed investors, amid weaker demand from its government customers and in Europe ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth ...

Credit cards face a threat from stablecoins, which offer a route to cheap, fast payments and could make a difference to consumers and retailers in the US who pay high fees for card transactions.

Novo Nordisk NOVO.B2.90%increase; green up pointing triangle said it would cut around 9,000 jobs, as its new chief executive tries to revive the drugmaker’s fortunes in the booming weight-loss market.

A new name could soon be seen among the usual Asus, ASRock, MSI, and Gigabyte motherboards outside China, as it looks as though another well-established gaming hardware firm is about to enter the fray ...

Axon Enterprise Inc.’s stock was up 15% as one of the top gainers in the S&P 500 on Wednesday after the Taser maker said budget cuts in Washington may help its business as it played up its prospects ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market. The Danish company has been battling it out with US ...

Novo Nordisk announced plans to cut about 9,000 jobs, or 11.5% of its global workforce, according to CNBC. The Danish pharmaceutical giant announced a company-wide transformation to streamline ...

Novo Nordisk NOVO.B-2.38%decrease; red down pointing triangle downgraded its guidance for the second time in six weeks as it announced a restructuring plan that will see it cut around 11% of its ...

Danish pharmaceutical giant Novo Nordisk announced Wednesday it would cut 11 percent of its workforce, as the maker of Ozempic and Wegovy faces rising competition for its anti-obesity treatments. The ...